For medical or commercial leaders in biopharma, the current COVID-19 pandemic has led to postponed clinical trials, stalled product launches, and lagging progress on strategic initiatives. This is before you even needed to create your organization’s current and long-term response to the current COVID-19 pandemic. A hiring freeze might prevent you from employing the Senior Medical Affairs Director that you desperately need to offset mounting accountabilities while the work just keeps piling up.
With so many unsettling changes in our world at the moment, Medical Affairs teams and life sciences organizations are trying to figure out how long things will stay in shutdown mode and when can we start thinking about getting life back to a “new normal”. The primary factors that will impact this timeline include how the U.S. testing program unfolds, how states choose to end social distancing and re-entry, and how the virus behaves over time.
Your organization cannot wait for the world to answer these questions. You and your organization need answers to critical questions now:
- How will COVID-19 impact your patient population?
- What messaging is important (and credible) for your people to have right now?
- How will telehealth and emerging technologies be used to fill gaps for your patients?
- How can medical and commercial work together to support your various patient groups?
Now, more than ever, it is critical to have evidence-based answers to these questions for what to do now and in the future–if you aren’t already being asked, you will be.
Marimac Insight was created to support innovative organizations with executive-level scientific leadership when and where they need it most. Our Fractional and Interim Medical Affairs support can bridge the gap for Life Sciences organizations navigating this and other emerging crises.
We help leaders across Life Sciences to sustain ongoing medical operations and gain an evidence-based understanding of the impact of this crisis on their products and markets. We’re working with our most proactive clients to make the best use of the current situation to shore-up strategic priorities and capture new momentum on re-entry.
If you’re ready to understand the impact of COVID-19 on your organization, contact us.